Successful treatment of systemic sclerosis digital ulcers and pulmonary arterial hypertension with endothelin receptor antagonist bosentan

被引：52
|
作者：
Humbert, M
Cabane, J
机构：
[1] Hop Antoine Beclere, Serv Pneumol & Reanimat Resp, Ctr Malad Vasc Pulm, F-92141 Clamart, France
[2] Hop St Antoine, Serv Med Interne, F-75571 Paris 12, France
来源：
RHEUMATOLOGY | 2003年 / 42卷 / 01期
关键词：
D O I：
10.1093/rheumatology/keg050
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：191 / 193
页数：3
相关论文
共 50 条
  • [1] Digital ulcers in systemic sclerosis - Prevention by treatment with bosentan, an oral endothelin receptor antagonist
    Korn, JH
    Mayes, M
    Cerinic, MM
    Rainisio, M
    Pope, J
    Hachulla, E
    Rich, E
    Carpentier, P
    Molitor, J
    Seibold, JR
    Hsu, V
    Guillevin, L
    Chatterjee, S
    Peter, HH
    Coppock, J
    Herrick, A
    Merkel, PA
    Simms, R
    Denton, CP
    Furst, D
    Nguyen, N
    Gaitonde, M
    Black, C
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (12): : 3985 - 3993
  • [2] Successful treatment of systemic sclerosis-related digital ulcers and sarcoidosis with endothelin receptor antagonist (bosentan) therapy
    Tillon, J
    Hervé, F
    Chevallier, D
    Muir, JF
    Levesque, H
    Marie, I
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2006, 154 (05) : 1000 - 1002
  • [3] Bosentan for the treatment of systemic sclerosis-associated pulmonary arterial hypertension, pulmonary fibrosis and digital ulcers
    Jain, Manu
    Varga, John
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (11) : 1487 - 1501
  • [4] SUCCESSFUL TREATMENT OF SYSTEMIC SCLEROSIS DIGITAL ULCERS WITH BOSENTAN
    Athanassiou, P.
    Kalaycheva, N.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (02) : S114 - S114
  • [5] Treatment of digital ulcers in systemtic sclerosis with endothelin-1 receptor antagonist (bosentan)
    Riccardi, M. T.
    Chiala, A.
    Iannone, F.
    Grattagliano, V.
    Covelli, M.
    Lapadula, G.
    [J]. REUMATISMO, 2007, 59 (02) : 135 - 139
  • [6] Endothelin-I receptor antagonist for the treatment of pulmonary arterial hypertension in systemic sclerosis
    John Varga
    [J]. Current Rheumatology Reports, 2003, 5 (2) : 145 - 146
  • [7] Successful Treatment of Systemic-Sclerosis-Related Digital Ulcers with a Selective Endothelin Type A Receptor Antagonist (Sitaxentan)
    Gholam, P.
    Sehr, T.
    Enk, A.
    Hartmann, M.
    [J]. DERMATOLOGY, 2009, 219 (02) : 171 - 173
  • [8] Bosentan treatment in pulmonary arterial hypertension secondary to systemic sclerosis
    Piludu, G.
    Nalli, E.
    Amoresano, D.
    Farci, M.
    Muttini, T.
    D'Aietti, I
    Mura, N.
    Loddo, M.
    Giacco, G.
    [J]. ALLERGY, 2008, 63 : 353 - 353
  • [9] Treatment of pulmonary arterial hypertension (PAH) with oral endothelin-receptor antagonist bosentan in systemic sclerosis: BREATHE-1 trial and clinical experience
    Ahmadi-Simab, K
    Lamprecht, P
    Hellmisch, B
    Gross, WL
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2004, 63 (06): : 495 - 497
  • [10] Role of the endothelin receptor antagonist bosentan in the treatment of patients with pulmonary hypertension
    Tsareva, N. A.
    [J]. TERAPEVTICHESKII ARKHIV, 2013, 85 (12): : 127 - 136
12345